Eltrombopag, a second-generation thrombopoietin receptor agonist, for chronic lymphocytic leukemia-associated ITP

Leukemia. 2010 May;24(5):1096-8. doi: 10.1038/leu.2010.45. Epub 2010 Mar 25.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects*
  • Benzoates / therapeutic use*
  • Drug Resistance, Neoplasm*
  • Female
  • Humans
  • Hydrazines / therapeutic use*
  • Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy*
  • Male
  • Middle Aged
  • Purpura, Thrombocytopenic, Idiopathic / chemically induced
  • Purpura, Thrombocytopenic, Idiopathic / drug therapy*
  • Pyrazoles / therapeutic use*
  • Receptors, Thrombopoietin / agonists*
  • Salvage Therapy

Substances

  • Benzoates
  • Hydrazines
  • Pyrazoles
  • Receptors, Thrombopoietin
  • eltrombopag